Comment
doi: 10.1016/j.eururo.2016.07.036.
Epub 2016 Aug 2.
Re: Re-evaluating PSA Testing Rates in the PLCO Trial
Affiliations
- PMID: 27495847
- DOI: 10.1016/j.eururo.2016.07.036
Item in Clipboard
Comment
Re: Re-evaluating PSA Testing Rates in the PLCO Trial
Eur Urol.
2016 Oct.
No abstract available
Comment on
-
Reevaluating PSA Testing Rates in the PLCO Trial.N Engl J Med. 2016 May 5;374(18):1795-6. doi: 10.1056/NEJMc1515131. N Engl J Med. 2016. PMID: 27144870 No abstract available.
Similar articles
-
Re: Reevaluating PSA Testing Rates in the PLCO Trial.Eur Urol. 2017 Feb;71(2):300. doi: 10.1016/j.eururo.2016.10.039. Epub 2016 Nov 4. Eur Urol. 2017. PMID: 27823819 No abstract available.
-
Re: Reevaluating PSA Testing Rates in the PLCO Trial.J Urol. 2016 Oct;196(4):1123-5. doi: 10.1016/j.juro.2016.07.065. Epub 2016 Jul 18. J Urol. 2016. PMID: 27628793 No abstract available.
-
More on Reevaluating PSA Testing Rates in the PLCO Trial.N Engl J Med. 2016 Oct 13;375(15):1500-1501. doi: 10.1056/NEJMc1607379. N Engl J Med. 2016. PMID: 27732807 No abstract available.
-
Guideline of guidelines: prostate cancer screening.BJU Int. 2014 Sep;114(3):323-5. doi: 10.1111/bju.12854. BJU Int. 2014. PMID: 24981126 Review. No abstract available.
-
Prostate-specific antigen testing and prostate cancer screening.Prim Care. 2010 Sep;37(3):441-59, vii. doi: 10.1016/j.pop.2010.05.001. Prim Care. 2010. PMID: 20705192 Review.
Cited by
-
The ERSPC Study: Quality Takes Time and Perseverance.Clin Chem. 2019 Jan;65(1):208-209. doi: 10.1373/clinchem.2018.287110. Epub 2018 Nov 20. Clin Chem. 2019. PMID: 30459163 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
